Latiglutenase is a dual enzyme investigational product designed to break down gluten in the stomach. Learn more about the trial and what this means for celiac disease patients.
Continue ReadingUkko, a startup focused on eradicating food allergies, intolerances, and sensitivities, has reached a promising stage in its effort to develop a gluten specifically designed for people with celiac disease.
Continue ReadingWe are determined to use every resource at our disposal, including strategic funding of research and advocacy, to help discover and bring to the celiac disease patient community therapeutic alternatives to the gluten-free diet.
Continue ReadingThe Celiac Disease Foundation is proud to announce its sponsorship of the April 17th University of Chicago’s Celiac Disease & The Continuum of Care Virtual CME Symposium.
Continue Reading9 Meters Biopharma, Inc., a clinical-stage company focused on rare and unmet needs in gastroenterology, announced their collaboration with the Celiac Disease Foundation to support clinical trial enrollment.
Continue ReadingFor the second consecutive year, the Celiac Disease Foundation hosted the Patient Education & Advocacy Summit.
Continue ReadingThe Celiac Disease Foundation recently published an article in Mediaplanet’s Autoimmune Diseases digital campaign.
Continue ReadingThe Celiac Disease Foundation is proud to have been involved by recruiting patients essential for this trial’s success.
Continue ReadingThe NIH Accelerating Progress in Celiac Disease Workshop is a direct outcome of our advocacy efforts in Washington, DC. CEO Marilyn Geller was invited to speak about what our celiac community needs. Watch her presentation here.
Continue ReadingAnokion SA announced that they have initiated patient dosing in the multiple ascending dose (MAD) portion of its ACeD study.
Continue ReadingDear Celiac Disease Foundation Community, For more than three decades, the Celiac Disease Foundation has been dedicated to improving the lives of those affected by celiac disease through research, advocacy, and education. What began as a grassroots effort has grown into a global organization, leading the charge in accelerating diagnosis,...